Lebrikizumab Found Effective for Patients With AD, SOC Lebrikizumab Found Effective for Patients With AD, SOC

Interim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Source Type: news